Trials / Sponsors / SGX Pharmaceuticals, Inc.
SGX Pharmaceuticals, Inc.
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Safety Study of SGX523, a Small Molecule Met Inhibitor, to Treat Solid Tumors Advanced Cancer | Phase 1 | 2008-01-01 |
| Terminated | Safety Study of SGX523, a Small Molecule Met Inhibitor, to Treat Solid Tumors Advanced Cancer | Phase 1 | 2008-01-01 |
| Terminated | Study for Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) Leukemia, Myeloid, Acute | Phase 2 | 2005-07-01 |
| Terminated | Study of Troxatyl™ Administered by Continuous Infusion to Subjects With Refractory Acute Myelogenous Leukemia Acute Myelogenous Leukemia | Phase 1 / Phase 2 | 2003-04-01 |
| Terminated | Study of Troxatyl™ Administered by Continuous Infusion to Subjects With Solid Tumors Neoplasms | Phase 1 / Phase 2 | 2003-01-01 |